Granulocyte response in vitro to isoproterenol, histamine, and prostaglandin E1, during treatment with beta-adrenergic aerosols in asthma.
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000328:Adult; D000336:Aerosols; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D000242:Cyclic AMP / Q000097:blood; D005966:Glucuronidase / Q000097:blood; D006098:Granulocytes / Q000187:drug effects* / Q000201:enzymology; D006632:Histamine / Q000494:pharmacology*; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology* / Q000627:therapeutic use; D008875:Middle Aged; D011458:Prostaglandins E / Q000494:pharmacology*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D011458:Prostaglandins E; D011943:Receptors, Adrenergic, beta; D006632:Histamine; D000242:Cyclic AMP; D005966:Glucuronidase; D007545:Isoproterenol; D000420:Albuterol